Investing $15,000 Into Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth $1 Million Today

[Pelican Press 0]

This is the hidden content, please

• Sign In
• or
• Sign Up

Investing $15,000 Into Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth $1 Million Today

Strategy, Mara Holdings, and Verona Pharma have each risen by more than 1,500% in the past five years.

Investments in speculative cryptocurrency plays like Strategy and Mara Holdings can pay off. They can also go quite badly.

Verona Pharma is a less speculative investment now that it has its first approved treatment on the market.

This is the hidden content, please

• Sign In
• or
• Sign Up

Advertisement: High Yield Savings Offers

Powered by Money.com – Yahoo may earn commission from the links above.

If you want to achieve significant gains in the stock market, you’ll probably want to plan to hold on and remain invested for many years, or even decades. But in some cases, big payoffs can come much faster than that. The benefit of investing in growth stocks is that they have the potential to deliver some terrific returns.

For example, growth stocks Strategy (NASDAQ: MSTR), Mara Holdings (NASDAQ: MARA), and Verona Pharma (NASDAQ: VRNA) have yielded fantastic gains for investors over the past five years. If you had invested $15,000 into each one of these stocks just five years ago and held on, you would have a portfolio worth more than $1 million today. The question is, do they still have the potential for further significant gains for investors who buy them right now?

Image source: Getty Images.

A $15,000 investment made five years ago into the company that at that time called itself MicroStrategy would now be worth around $458,000. That’s a staggering return when you consider that its core technology business hasn’t been taking off. The company, which earlier this year shortened its name to Strategy, has actually experienced a decline in revenue in recent years. While it’s nominally involved in providing business intelligence solutions, the reason its stock skyrocketed was tied to its aggressive moves in the cryptocurrency space.

Strategy is the largest corporate holder of Bitcoin (CRYPTO: BTC), with a stash that now totals more than 500,000 coins. The company routinely updates investors on its position and Bitcoin holdings. Executive Chairman Michael Saylor is incredibly bullish on the popular digital currency’s potential value, predicting that its token price will climb to well over $1 million in the future, and suggesting that it could potentially top $13 million by 2045.

Strategy stock could still rise higher if Bitcoin does well. But it’s a highly speculative buy: Its valuation is not tied to its overall performance, but is instead contingent on how strong the crypto market is. If you’re bullish about that, you may feel that the stock could be a good buy. But for the majority of investors, this investment is likely to be too risky and speculative to hold.

Story Continues

Bitcoin mining company Mara has also benefited from the cryptocurrency’s rising value over the past five years. During that stretch, a $15,000 investment into the stock would have grown into a holding worth approximately $290,000. Remarkably, that result includes a steep drop that it hasn’t fully recovered from yet: The

This is the hidden content, please

• Sign In
• or
• Sign Up

is down by more than 50% from where it began 2022.

In the past three years, the company’s bottom line has fluctuated drastically, from a loss of more than $694 million in 2022 to a profit of $541 million in 2024, and the stock has been similarly volatile. Its performance inevitably hinges on the changes in the market value of the digital assets it mines and holds.

As with Strategy, this is a speculative buy, as Mara’s valuation will ultimately depend on how well Bitcoin is doing. This isn’t a stock I’d suggest owning unless you have an extremely high risk tolerance.

The only stock on this list that hasn’t amassed its gains due to crypto is Verona Pharma. However, the biopharmaceutical company has still generated impressive returns for investors. A $15,000 investment in the business five years ago would now be worth $267,000. Add that to the gains from your hypothetical $15,000 investments in the other two companies mentioned, and you’d have around $1.02 million.

Shares of Verona started to take off in June 2024 after the company obtained Food and Drug Administration approval for Ohtuvayre as a maintenance treatment for chronic obstructive pulmonary disease. Analysts believe Ohtuvayre can become a

This is the hidden content, please

• Sign In
• or
• Sign Up

, generating more than $1 billion in annual revenue for Verona by 2029.

Verona incurred a loss of more than $173 million last year, but with Ohtuvayre already beginning to generate sales, the business is on a much more positive trajectory. The stock’s valuation isn’t cheap, as its market cap is hovering around $7 billion. But given its promising growth prospects and its possible path to profitability, it’s the only stock on this list that I’d consider buying today.

Before you buy stock in Strategy, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 

This is the hidden content, please

• Sign In
• or
• Sign Up

for investors to buy now… and Strategy wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when 

This is the hidden content, please

• Sign In
• or
• Sign Up

 made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $668,538!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $869,841!*

Now, it’s worth noting Stock Advisor’s total average return is 789% — a market-crushing outperformance compared to 172% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

This is the hidden content, please

• Sign In
• or
• Sign Up

*Stock Advisor returns as of June 2, 2025

This is the hidden content, please

• Sign In
• or
• Sign Up

has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Bitcoin. The Motley Fool has a

This is the hidden content, please

• Sign In
• or
• Sign Up

.

This is the hidden content, please

• Sign In
• or
• Sign Up

was originally published by The Motley Fool

This is the hidden content, please

• Sign In
• or
• Sign Up

#Investing #Stocks #Years #Created #Portfolio #Worth #Million #Today

This is the hidden content, please

• Sign In
• or
• Sign Up

This is the hidden content, please

• Sign In
• or
• Sign Up

For verified travel tips and real support, visit: https://hopzone.eu/